European Archives - Page 6 of 1171 - European Medical Journal

Pharma seized the spotlight at Cannes Lions – here's why

In a departure from years past, Cannes Lions 2025 saved a sizable percentage of their praise for companies in the pharma space.

Hyperbaric Oxygen Therapy Leads Diabetic Foot Ulcer Treatment Rankings in New Meta-Analysis

Hyperbaric oxygen therapy ranks highest for healing diabetic foot ulcers but may raise amputation risk, new network meta-analysis reveals.

Study Links Bifidobacterium Deficit in Infants in the USA to Gut Dysbiosis

One in four U.S. infants lacks Bifidobacterium, a key gut microbe essential for immune and metabolic health.

Head-to-Head Trial Supports Cheaper Hepatitis C Drug

Beyond the head-to-head comparison, the study also explored innovative strategies to simplify or shorten treatment.

Illustration of scientific tools

New report calls for faster R&D for rare diseases

A report has found that while many in the UK live with rare diseases, systemic failures continue to restrict progress in treatment.

GSK’s Matt Mortimer-Ryan on behaviour-led pharma marketing

Matt Mortimer Ryan, GSK, discusses how understanding patients’ emotional drivers can unlock more impactful pharma marketing campaigns.

Unusual Yeast Fungaemia Patterns Seen in Injection Drug Users

French researchers report distinct fungal species in intravenous drug users with yeast fungaemia, suggesting the need for tailored care strategies.

PARP Inhibitor Shows Promise in Advanced Melanoma Treatment

The study highlights how HR pathway alterations, which affect roughly a fifth to a third of melanomas, may offer an opportunity for targeted treatment.

GLP-1s Reduces Heart Failure and Kidney Complications in Monoclonal Gammopathy and Type 2 Diabetes

GLP-1 receptor agonists cut heart, stroke, and kidney risks in people with MGUS and diabetes, new study finds.

Positive Feedback Boosts Performance in Urological Surgical Training

These insights are particularly relevant in minimally invasive surgery, where precision and confidence are vital.